Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001209191-22-037146

Chief Operating Officer returned 802 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
HIGH SUSANNA GATTI Chief Operating Officer 2022-06-14 Returned to the company −802 $4.95 $3,970 72,201 D
Loading xslF345X03/doc4.xml…